Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 14, Issue 1, 2007, Pages 59-67

  Tanaka, Atsushi ^a   Takada, Tadahiro ^a   Kawarada, Yoshifumi ^b   Nimura, Yuji ^c   Yoshida, Masahiro ^a   Miura, Fumihiko ^a   Hirota, Masahiko ^d   Wada, Keita ^a   Mayumi, Toshihiko ^e   Gomi, Harumi ^f   Solomkin, Joseph S ^g   Strasberg, Steven M ^h   Pitt, Henry A ⁱ   Belghiti, Jacques ^j   de Santibanes, Eduardo ^k   Padbury, Robert ^l   Chen, Miin Fu ^m   Belli, Giulio ⁿ   Ker, Chen Guo ^o   Hilvano, Serafin C ^p   Fan, Sheung Tat ^q   Liau, Kui Hin ^r   more..

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^h BARNES JEWISH HOSPITAL   (United States)

ⁱ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BEAUJON HOSPITAL   (France)

^k UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^l FLINDERS MEDICAL CENTRE   (Australia)

^m CHANG GUNG UNIVERSITY   (Taiwan)

ⁿ Loreto Nuovo Hospital   (Italy)

^o YUAN'S GENERAL HOSPITAL   (Taiwan)

^p UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^q UNIVERSITY OF HONG KONG   (Hong Kong)

^r TAN TOCK SENG HOSPITAL   (Singapore)

more..

Author keywords

Anti infective agents; Biliary; Cholangitis; Guidelines; Infection

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; ASPOXICILLIN; AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOPERAZONE; CEFOTIAM; CEFOZOPRAN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; FLOMOXEF; LATAMOXEF; LEVOFLOXACIN; MEROPENEM; PAZUFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; UNINDEXED DRUG;

ACUTE DISEASE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; BILE; CHOLANGITIS; CLINICAL TRIAL; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG PENETRATION; HUMAN; MICROBIOLOGICAL EXAMINATION; PRACTICE GUIDELINE; TISSUE CULTURE;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BILE; CEFTRIAXONE; CHOLANGITIS; HUMANS;

EID: 33846657763     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-006-1157-6     Document Type: Article

References (42)

1. HA Pitt R Postier J Cameron 1983 Consequences of preoperative cholangitis and its treatment on the outcome of operation for choledocholithiasis Surgery 94 447-52 6612580 1:STN:280:BiyA3c3msF0%3D level 2b
2. F Maluenda A Csendes P Burdiles J Diaz 1989 Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis Hepatogastroenterology 36 132-5 2502489 1:STN:280:BiaA38njslM%3D level 3b
3. B Claesson 1986 Microflora of the biliary tree and liver - clinical correlates Dig Dis 4 93-118 3545564 1:STN:280:BiiC3s7nsFA%3D level 5
4. W Chang K Lee S Wang S Chuang K Kuo J Chen 2002 Bacteriology and antimicrobial susceptibility in biliary tract disease: An audit of 10-year's experience Kaohsiung J Med Sci 18 221-8 12197428 level 3b
5. A Csendes P Burdiles F Maluenda J Diaz P Csendes N Mitru 1996 Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones Arch Surg 131 389-94 8615724 1:STN:280:BymB3c7ltVA%3D level 2b
6. A Csendes N Mitru F Maluenda J Diaz P Burdiles P Csendes 1996 Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis Hepatogastroenterology 43 800-6 8884293 1:STN:280:ByiD3sfntFY%3D level 2b
7. B Brismar K Jalakas A Malmborg A Strandberg 1986 The significance of bacteriological findings at cholecystectomy Acta Chir Scand 530 Suppl 35-8 1:STN:280:BimB28vjtVc%3D level 3b
8. H Jarvinen 1980 Biliary bacteremia at various stages of acute cholecystitis Acta Chir Scand 146 427-30 7468075 1:STN:280:Bi6C38blslI%3D level 2b
9. L Hanau N Steigbigel 2000 Acute (ascending) cholangitis Infect Dis Clin North Am 14 521-46 10987108 10.1016/S0891-5520(05)70119-7 1:STN:280:DC%2BD3M7hsVShug%3D%3D level 4
10. J Westphal J Brogard 1999 Biliary tract infections: A guide to drug treatment Drugs 57 81-91 9951953 10.2165/00003495-199957010-00007 1:STN:280:DyaK1M7jsFChtg%3D%3D level 5
11. M Sinanan 1992 Acute cholangitis Infect Dis Clin North Am 6 571-99 1431039 1:STN:280:ByyD2MnjvFQ%3D level 5
12. C Marne R Pallares R Martin A Sitges-Serra 1986 Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile Eur J Clin Microbiol 5 35-9 2870920 10.1007/BF02013458 1:STN:280:BimC1M3kt1c%3D level 3b
13. B Claesson D Holmlund T Matzsch 1986 Microflora of the gallbladder related to duration of acute cholecystitis Surg Gynecol Obstet 162 531-5 3715685 1:STN:280:BimB3srpslA%3D level 2b
14. M Nielsen T Justesen 1976 Anaerobic and aerobic bacteriological studies in biliary tract disease Scand J Gastroenterol 11 437-46 785585 1:STN:280:CSmB2s%2FpvVA%3D level 3b
15. L Hanau N Steigbigel 1995 Cholangitis: Pathogenesis, diagnosis, and treatment Curr Clin Top Infect Dis 15 153-78 7546366 1:STN:280:BymD383ptFM%3D level 4
16. JE Thompson Jr R Bennion HA Pitt 1994 An analysis of infectious failures in acute cholangitis HPB Surg 8 139-45 7880773 1:STN:280:ByqC1cnktF0%3D level 4
17. RP Dellinger JM Carlet H Masur H Gerlach T Calandra J Cohen 2004 for the Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 858-73 15090974 10.1097/ 01.CCM.0000117317.18092.E4 level 4
18. D Gilbert R Moellering Jr M Sande 2003 The Sanford guide to antimicrobial therapy 33rd ed Antimicrobial therapy Hyde Park, VT level 4
19. LL Brunton JS Lazo KL Parker 2006 Goodman and Gilman's the pharmacological basis of therapeutics 11th ed McGraw-Hill New York level 4
20. J Leung T Ling R Chan S Cheung C Lai J Sung 1994 Antibiotics, biliary sepsis, and bile duct stones Gastrointest Endosc 40 716-21 7859970 1:STN:280:ByqC28zot1w%3D level 3b
21. O Martinez J Levi R Devlin 1984 Biliary excretion of aztreonam in patients with biliary tract disease Antimicrob Agents Chemother 25 358-61 6539092 1:STN:280:BiuB3c7nt1U%3D level 4
22. J Leung C Chan C Lai T Ko A Cheng G French 1992 Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin Antimicrob Agents Chemother 36 2057-60 1416901 1:STN:280:ByyD3sjjsF0%3D level 3b
23. J Leung R Chan S Cheung J Sung S Chung G French 1990 The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime J Antimicrob Chemother 25 399-406 2187012 10.1093/jac/25.3.399 1:STN:280:By%2BB2M%2FgvVA%3D level 4
24. J Blenkharn N Habib D Mok L John G McPherson R Gibson 1985 Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice Antimicrob Agents Chemother 28 778-80 4083861 1:STN:280:BimC3c3gtVI%3D level 4
25. S van den Hazel X De Vries P Speelman J Dankert G Tytgat K Huibregtse 1996 Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract Antimicrob Agents Chemother 40 2658-60 8913485 1:CAS:528:DyaK28Xms1Smt78%3D level 4
26. T Takada F Hanyu Y Fukushima Y Uchida T Imaizumi H Yasuda 1976 Excretion of antibiotics into human bile juice in patients with obstructive jaundice (in Japanese) Jpn J Gastroenterol 73 39-47 level 4
27. J Levi O Martinez T Malinin R Zeppa A Livingstone D Hutson 1984 Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction Antimicrob Agents Chemother 26 944-6 6524908 1:STN:280:BiqC38%2FnvFY%3D level 4
28. J Boey L Way 1980 Acute cholangitis Ann Surg 191 264-70 7362292 10.1097/ 00000658-198003000-00002 1:STN:280:Bi%2BC2M3jvFc%3D level 5
29. JE Thompson Jr R Tompkins WJ Longmire 1982 Factors in management of acute cholangitis Ann Surg 195 137-45 7055389 level 4
30. E Muller HA Pitt JE Thompson Jr J Doty L Mann B Manchester 1987 Antibiotics in infections of the biliary tract Surg Gynecol Obstet 165 285-92 3310282 1:STN:280:BieD3MfktlA%3D level 2b
31. W Gerecht N Henry W Hoffman S Muller N LaRusso J Rosenblatt 1989 Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis Arch Intern Med 149 1279-84 2658897 10.1001/archinte.149.6.1279 1:STN:280:BiaB2s3ksVA%3D level 2b
32. JE Thompson Jr HA Pitt J Doty J Coleman C Irving 1990 Broad spectrum penicillin as an adequate therapy for acute cholangitis Surg Gynecol Obstet 171 275-82 2218831 level 2b
33. J Chacon P Criscuolo C Kobata J Ferraro S Saad C Reis 1990 Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections J Antimicrob Chemother 26 Suppl B 167-72 2258344 level 2b
34. JE Thompson Jr R Bennion R Roettger K Lally J Hopkins SE Wilson 1993 Cefepime for infections of the biliary tract Surg Gynecol Obstet 177 Suppl 30-4 8256189 level 2b
35. J Sung D Lyon R Suen S Chung A Co A Cheng 1995 Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: A randomized, controlled clinical trial J Antimicrob Chemother 35 855-64 7559196 10.1093/jac/35.6.855 1:CAS:528:DyaK2MXmslKls7w%3D level 2b
36. J Solomkin J Mazuski E Baron R Sawyer A Nathens J DiPiro 2003 Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections Clin Infect Dis 37 997-1005 14523762 10.1086/ 378702 level 4
37. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group 1994 Results of the North American trial of piperacillin/ tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections Eur J Surg 573 Suppl 61-6 level 2b
38. J Sales M Sutcliffe F O'Grady 1973 Excretion of clindamycin in the bile of patients with biliary tract disease Chemotherapy 19 11-5 4747573 1:STN:280:CSuD3MrptVQ%3D level 4
39. A Csendes M Becerra P Burdiles I Demian K Bancalari P Csendes 1994 Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease Eur J Surg 160 363-7 7948355 1:STN:280:ByqD3srksVU%3D level 2b
40. A Csendes M Fernandez P Uribe 1975 Bacteriology of the gallbladder bile in normal subjects Am J Surg 129 629-31 805546 10.1016/ 0002-9610(75)90334-7 1:STN:280:CSqC283ltVU%3D level 3b
41. G Kune E Schutz 1974 Bacteria in the billary tract. A study of their frequency and type Med J Aust 1 255-8 4821535 1:STN:280:CSuC2c%2FlsFc%3D level 3b
42. R Orda S Berger Y Levy A Shnaker A Gorea 1992 Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitis Dig Dis Sci 37 1691-3 1425067 10.1007/BF01299860 1:STN:280:ByyD2cfks1E%3D level 4